HealthEquity (HQY)
(Delayed Data from NSDQ)
$79.56 USD
+2.47 (3.20%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $79.51 -0.05 (-0.06%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Company Summary
Draper, UT-headquartered HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States.
HealthEquity uses its innovative technology to manage consumers' tax-advantaged HSAs and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. As part of its services, HealthEquity provides consumers with healthcare bill evaluation and payment processing services, personalized benefit information, including information on treatment ...
Company Summary
Draper, UT-headquartered HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States.
HealthEquity uses its innovative technology to manage consumers' tax-advantaged HSAs and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. As part of its services, HealthEquity provides consumers with healthcare bill evaluation and payment processing services, personalized benefit information, including information on treatment options and comparative pricing, access to remote and telemedicine benefits, the ability to earn wellness incentives and investment advice to grow their tax-advantaged healthcare savings.
In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
As of Jan 31, 2023, HealthEquity had substantially completed its efforts to phase out certain technology platforms that it acquired in the acquisition of its wholly-owned subsidiary, WageWorks, Inc. and migrated the associated clients to one of its other technology platforms. The company is also working to phase out a technology platform that it acquired in the Further Acquisition, which requires it to migrate the associated clients to one of its other technology platforms. HealthEquity acquired an additional technology platform as part of the Luum Acquisition, which provides clients with various commuter services, including access to real-time commute data, to help clients design and implement flexible return-to-office and hybrid-workplace strategies and benefits.
FY24 at a Glance
In fiscal 2024, HealthEquity reported revenues of $999.6 million, up 16% over FY23.
HealthEquity derives revenues from three sources — Service revenues (45.6% of net revenues, up 0.8% over FY23), Custodial revenues (38.7%, up 47.9%) and Interchange revenues (15.7%, up 5.9%).
General Information
HealthEquity, Inc
15 WEST SCENIC POINTE DRIVE SUITE 100
DRAPER, UT 84020
Phone: 801-727-1000
Fax: 801-727-1005
Web: http://www.healthequity.com
Email: rputnam@healthequity.com
Industry | Medical Services |
Sector | Medical |
Fiscal Year End | January |
Last Reported Quarter | 7/31/2024 |
Earnings Date | 9/3/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 0.70 |
Current Year EPS Consensus Estimate | 3.00 |
Estimated Long-Term EPS Growth Rate | 28.00 |
Earnings Date | 9/3/2024 |
Price and Volume Information
Zacks Rank | ![]() |
Yesterday's Close | 77.09 |
52 Week High | 88.26 |
52 Week Low | 61.81 |
Beta | 0.52 |
20 Day Moving Average | 535,403.88 |
Target Price Consensus | 104.43 |
4 Week | 11.41 |
12 Week | -6.67 |
YTD | 20.00 |
4 Week | 5.46 |
12 Week | -11.66 |
YTD | 1.33 |
Shares Outstanding (millions) | 87.01 |
Market Capitalization (millions) | 6,922.56 |
Short Ratio | NA |
Last Split Date | NA |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 26.50 |
Trailing 12 Months | 31.08 |
PEG Ratio | 0.95 |
vs. Previous Year | 71.88% |
vs. Previous Quarter | 10.00% |
vs. Previous Year | 17.66% |
vs. Previous Quarter | 9.61% |
Price/Book | 3.30 |
Price/Cash Flow | 23.27 |
Price / Sales | 6.64 |
7/31/24 | Pending Next EPS Report |
4/30/24 | 7.77 |
1/31/24 | 6.91 |
7/31/24 | Pending Next EPS Report |
4/30/24 | 4.99 |
1/31/24 | 4.41 |
7/31/24 | Pending Next EPS Report |
4/30/24 | 4.39 |
1/31/24 | 4.76 |
7/31/24 | Pending Next EPS Report |
4/30/24 | 4.39 |
1/31/24 | 4.76 |
7/31/24 | Pending Next EPS Report |
4/30/24 | 15.04 |
1/31/24 | 13.64 |
7/31/24 | Pending Next EPS Report |
4/30/24 | 7.71 |
1/31/24 | 5.57 |
7/31/24 | Pending Next EPS Report |
4/30/24 | 9.42 |
1/31/24 | 7.51 |
7/31/24 | Pending Next EPS Report |
4/30/24 | 24.11 |
1/31/24 | 23.72 |
7/31/24 | NA |
4/30/24 | NA |
1/31/24 | NA |
7/31/24 | Pending Next EPS Report |
4/30/24 | 0.44 |
1/31/24 | 0.43 |
7/31/24 | Pending Next EPS Report |
4/30/24 | 30.62 |
1/31/24 | 30.07 |